Breathe Easier:
Cellular Therapy for Lung Disease

At the Lung Institute, we are an innovative leader of regenerative medicine dedicated to providing cellular therapies for lung disease. Through our commitment of offering patients a more effective way to address pulmonary conditions, we are improving lives.

Learn About Our Cellular Therapy Process

Advantages of Cellular Therapy (PRP-PC)

Traditional medical treatments only address the symptoms. Our natural treatments and wellness approach can provide our patients with a more effective way to address chronic inflammatory lung diseases. We are improving lives and helping people breathe easier.

    We have received national accreditation as a top healthcare organization providing safe, high quality care to our patients.
    Move beyond traditional treatments that only address symptoms. Our integrated wellness approach addresses the root cause.
    Our outpatient therapy requires no downtime or post-therapy restrictions.
    Based on patient surveys following treatment.
    Our integrated wellness approach has the potential to calm lung inflammation, and to slow lung disease progression.
    A new approach to your lung health. Our doctors are board-certified and our clinicians undergo rigorous training.
    Based on patient surveys, 85% of patients report quality-of-life improvements at three months of treatment.

Start your Journey to Breathe Easier

A patient care coordinator is waiting to hear from you. Contact us today to schedule your free consultation. Call Toll-free 888-745-6697

Lung Diseases Treated with Cellular Therapy

The Lung Institute treats a number of both restrictive and obstructive lung diseases. Since opening our doors in 2013, we’ve treated over 4,600 patients, and many patients have reported seeing an increase in their quality of life.

At the Lung Institute, we can provide cellular therapy for the following lung diseases:

* Every patient is given a Patient Satisfaction Survey shortly after treatment. Responses to the 11-question survey are aggregated to determine patient satisfaction with the delivery of treatment.

^ Quality of Life Survey data measured the patient’s self-assessed quality of life and measurable quality of improvement at three months of COPD patients.

All claims made regarding the efficacy of Lung Institute's treatments as they pertain to pulmonary conditions are based solely on anecdotal support collected by Lung Institute. Individual conditions, treatment and outcomes may vary and are not necessarily indicative of future results. Testimonial participation is voluntary. Lung Institute does not pay for or script patient testimonials.

As required by Texas state law, the Lung Institute Dallas Clinic has received Institutional Review Board (IRB) approval from MaGil IRB, now Chesapeake IRB, which is fully accredited by the Association for the Accreditation of Human Research Protection Program (AAHRPP), for research protocols and procedures. The Lung Institute has implemented these IRB approved standards at all of its clinics nationwide. Approval indicates that we follow rigorous standards for ethics, quality, and protections for human research.

Each patient is different. Results may vary.